B2M and neoplasm: Recent publications demonstrate a clonal evolution of tumors with LOH-6, involving the HLA genes, suggesting that this alteration is an early event in carcinogenesis and combined with other alterations, such as mutations in β2M or other genes involved in antigen presentation, could drive tumor evolution towards a more advanced stage.